NEW YORK — U.S. stocks rose across the board Wednesday following big gains in Asia and Europe, a buoyant end to the worst quarter for the market in four years.
From worries over a slowing Chinese economy, uncertainty over interest rates and a scary slide in commodity prices, stocks have been hit with one blow after another in the past three months. But on Wednesday, investors were in the mood to buy, especially stocks that have been battered recently. Energy companies and raw material suppliers, the biggest losers in the quarter, rose more than 2 percent each.
The buying began at the opening of trading and swept across all 10 sectors of the Standard and Poor’s 500 index. Among the big gainers, fashion company Ralph Lauren jumped 14 percent after announcing a new CEO would take over from its namesake founder.
Tim Courtney, chief investment officer of Exencial Wealth Advisors, said it was only a matter of time before investors started buying given the recent drops.
“I’ve been surprised we haven’t had rallies like the one we’re seeing now,” Courtney said. After “so many negative days, you’re going to get a bounceback.”
The S&P 500 jumped 35.94 points, or 1.9 percent, to 1,920.03. The index has fallen seven of the past 10 days, and is off 6.9 percent in the July-September period, the worst quarterly performance since 2011.
The Dow Jones industrial average gained 235.57 points, or 1.5 percent, to 16,284.70. It fell 7.6 percent in the quarter. The Nasdaq composite climbed 102.84 points, or 2.3 percent, to 4,620.16.
The rally in the U.S. followed even bigger gains overseas. Stocks indexes in France, Germany, Britain and Japan all climbed more than 2 percent.
Send questions/comments to the editors.
-
Community
Art show shines spotlight on Maine Media students
-
Nation & World
Biden’s global climate summit closes with call for investment now to ensure prosperity later
-
New England
Connecticut racial equity meeting interrupted with racist slurs, images
-
Local & State
Campaign to promote municipal employment features Gardiner police officer amid candidate crunch
-
Health care
U.S. health panel reviews J&J vaccine pause over rare clots
Success. Please wait for the page to reload. If the page does not reload within 5 seconds, please refresh the page.
Enter your email and password to access comments.
Hi {SUB NAME}, to comment on stories you must . This profile is in addition to your subscription and website login.
Already have one? .
Invalid username/password.
Please check your email to confirm and complete your registration.
Only subscribers are eligible to post comments. Please subscribe or login to participate in the conversation. Here’s why.
Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.